Compare CORT & APPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CORT | APPF |
|---|---|---|
| Founded | 1998 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 6.4B |
| IPO Year | 2001 | 2015 |
| Metric | CORT | APPF |
|---|---|---|
| Price | $117.17 | $195.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | $96.50 | ★ $286.78 |
| AVG Volume (30 Days) | ★ 1.2M | 440.0K |
| Earning Date | 04-30-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.09 | ★ 2.36 |
| Revenue | $761,407,000.00 | ★ $950,822,000.00 |
| Revenue This Year | $26.08 | $19.69 |
| Revenue Next Year | $26.98 | $16.70 |
| P/E Ratio | $1,271.89 | ★ $86.53 |
| Revenue Growth | 12.79 | ★ 19.72 |
| 52 Week Low | $28.66 | $142.56 |
| 52 Week High | $122.21 | $285.61 |
| Indicator | CORT | APPF |
|---|---|---|
| Relative Strength Index (RSI) | 66.55 | 56.89 |
| Support Level | $76.41 | $157.79 |
| Resistance Level | $122.21 | $240.32 |
| Average True Range (ATR) | 5.00 | 8.53 |
| MACD | -0.00 | 0.61 |
| Stochastic Oscillator | 81.48 | 67.02 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
AppFolio Inc provides cloud-based software solutions for the real estate industry. Its property management software offers property managers an end-to-end solution to their business needs. The group's products include cloud-based property management software (Appfolio Property Manager). Its solutions are AppFolio Property Manager Core, AppFolio Property Manager Plus, and AppFolio Property Manager Max. It also offers value-added services, such as screening, risk mitigation, and electronic payment services. Its markets are Single-Family, Multifamily, Student Housing, Affordable Housing, Community Associations, Commercial, and Investment Management. The business activity of the firm predominantly functions in the United States and it generates revenue in the form of subscription fees.